Bioventus (BVS) Other Gross PP&E Adjustments (2020 - 2026)
Bioventus (BVS) reported Other Gross PP&E Adjustments of -$4.7 million for Q1 2026, up 62.14% on a YoY basis from -$2.9 million in Q1 2025, and down 107.22% quarter-over-quarter from $64.9 million in Q4 2025.
Bioventus (BVS) Other Gross PP&E Adjustments (2020 - 2026) Analysis & Trends
Bioventus has reported Other Gross PP&E Adjustments for 7 years, with the latest figure at -$4.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 62.14% year-over-year to -$4.7 million; the trailing twelve-month figure through Mar 2026 stood at -$4.7 million (up 62.14% YoY), and the FY2025 full-year result was $64.9 million, up 5.66% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$4.7 million, down from $64.9 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $64.9 million in Q4 2025, with the low at -$38.1 million in Q2 2023.
- Historically, Other Gross PP&E Adjustments has averaged $7.7 million across 5 years, with a median of -$12.0 million in 2025.
- Annual changes were most pronounced in 2024 — Other Gross PP&E Adjustments surged 344.3% — and 2025, when it plunged 126.87%.
- Bioventus' Other Gross PP&E Adjustments stood at $41.6 million in 2022, then soared by 47.67% to $61.4 million in 2023, then gained by 0.15% to $61.5 million in 2024, then rose by 5.66% to $64.9 million in 2025, then sank by 107.22% to -$4.7 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$4.7 million (Q1 2026), $64.9 million (Q4 2025), and -$11.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -99.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 5.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.39 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 991.00 Mn |
| 10 | Bioventus | 571.68 Mn | 581.20 Mn | 90.77 Mn | -4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -4.69 Mn |
| Mar 28, 2026 | -4.69 Mn |
| Dec 31, 2025 | 64.94 Mn |
| Dec 31, 2025 | 64.94 Mn |
| Sep 27, 2025 | -11.61 Mn |
| Sep 27, 2025 | -11.61 Mn |
| Jun 28, 2025 | -11.99 Mn |
| Jun 28, 2025 | -11.99 Mn |
| Mar 29, 2025 | -12.38 Mn |
| Mar 29, 2025 | -12.38 Mn |
| Dec 31, 2024 | 61.46 Mn |
| Dec 31, 2024 | 61.46 Mn |
| Sep 28, 2024 | 52.72 Mn |
| Sep 28, 2024 | 52.72 Mn |
| Jun 29, 2024 | 44.63 Mn |
| Jun 29, 2024 | 44.63 Mn |
| Mar 30, 2024 | -13.88 Mn |
| Mar 30, 2024 | -13.88 Mn |
| Dec 31, 2023 | 61.37 Mn |
| Dec 31, 2023 | 61.37 Mn |